Overview of comments received on 'Reflection paper on the application of Article 40(5) of Regulation (EU) 2019/6 for certain categories of variations' (EMA/CVMP/55240/2025)

Overview of comments received on 'Reflection paper on the application of Article 40(5) of Regulation (EU) 2019/6 for certain categories of variations' (EMA/CVMP/55240/2025)

Draft reflection paper on data recommendations for herbal medicinal products and traditional herbal medicinal products used in children and adolescents

Draft reflection paper on data recommendations for herbal medicinal products and traditional herbal medicinal products used in children and adolescents

Human medicines European public assessment report (EPAR): NovoRapid, insulin aspart, Date of authorisation: 07/09/1999, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): NovoRapid, insulin aspart, Date of authorisation: 07/09/1999, Revision: 34, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness